Issue

Federal Register Volume 89 Issue 71 (Thursday, April 11, 2024)

This issue includes canonical document pages and full document metadata.

Health and Human Services Department

  1. Determination That VISTARIL (Hydroxyzine Pamoate) Oral Suspension, 25 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or EffectivenessNotice ยท 89 FR 25631